VTM-C19 Transit Tube
VTM-C19 Transit Tube
A premium transport device for use with nucleic acid testing of SARS-CoV-2 specimens
Biomed Diagnostics' VTM-C19 Transit Tube is intended for on-site collection and transport to the testing laboratory of human clinical specimens containing SARS-CoV-2 — the virus that causes COVID-19 disease in humans. 1,2
Intended to be inoculated with specimens collected with a nasopharyngeal (NP) or oropharyngeal (OP) synthetic fiber swab (not provided), VTM-C19 has been validated to transport SARS-CoV-2 viral specimen appropriately to the lab for analysis with qRT-PCR.
Specifications
| Product Principle | • VTM-C19 Transit Tubes ensures a non-replicating competent status of SARS-CoV-2 (COVID-19) |
|---|---|
| Simple Convenience | • Safe transport and preservation of the specimen |
| Storage | • Do not freeze the VTM-C19 Transit Tube. The VTM-C19 Transit Tube is based on the CDC formulation which has a shelf-life of twelve-months when stored at 2 – 8°C. However, due to the ongoing COVID-19 emergency, shelf-life testing is currently on-going. The product label reflects the expiry date relative to current internal data acquired for product stored at at 2 – 8°C. Please contact us for any further information. |
Transportation
The VTM-C19 Transit Tube is designed for safe transport. Inoculated tubes should be transported within 72 hours after inoculation and maintained at 2-8°C. 2
Regulatory
For In Vitro Diagnostic Use.
For export only; not for sale in USA. Not available in all countries; please inquire.
Reference
- Centers for Disease Control and Prevention (CDC) Laboratory Outreach Communication System SOP post on 3-21-20: cdc.gov/coronavirus/2019-ncov/downloads/Viral-Transport-Medium.pdf
- FDA authorized instructions for use. fda.gov/media/134922/download
- CDC preventing transmission of infectious agents in healthcare settings guidelines; cdc.gov/infectioncontrol/guidelines/isolation